Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?(647 views) Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Department of Formative Processes, University of Catania, Catania, Italy
Department of Clinical and Molecular Biomedicine, Section of Pharmacology, University of Catania, Catania 95125, Italy
I.N.M. Neuromed, Località Camerelle, 86077 Pozzilli, Italy
Department of Drug Sciences, University of Catania, Catania, Italy
I.B.B., CNR-Catania, 95125 Catania, Italy
Department of Human Physiology and Pharmacology, University of Rome, Sapienza, Piazzale Aldo Moro, 5, 00185 Rome, Italy
I. N. M. Neuromed, Localit Camerelle, 86077 Pozzilli, Italy
I. B. B., CNR-Catania, 95125 Catania, Italy
References: Albers, G.W., Goldberg, M.P., Choi, D.W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40
Ambrosini, A., Bresciani, L., Fracchia, S., Brunello, N., Racagni, G., Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-d-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro (1995) Mol. Pharmacol., 47, pp. 1057-1064
Armentero, M.T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9
Aronica, E., Catania, M.V., Geurts, J., Yankaya, B., Troost, D., Immunohistochemical localization of group i and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: Upregulation in reactive astrocytes (2001) Neuroscience, 105, pp. 509-520
Aronica, E., Gorter, J.A., Ijlst-Keizers, H., Rozemuller, A.J., Yankaya, B., Leenstra, S., Troost, D., Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins (2003) Eur. J. Neurosci., 17, pp. 2106-2118
Attucci, S., Carlà, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806
Balázs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C.W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163
Battaglia, G., Bruno, V., Ngomba, R.T., Di Grezia, R., Copani, A., Nicoletti, F., Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death (1998) Eur. J. Pharmacol., 356, pp. 271-274
Battaglia, G., Busceti, C.L., Molinaro, G., Biagioni, F., Storto, M., Fornai, F., Nicoletti, F., Bruno, V., Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (2004) J. Neurosci., 24, pp. 828-835
Battaglia, G., Molinaro, G., Riozzi, B., Storto, M., Busceti, C.L., Spinsanti, P., Bucci, D., Bruno, V., Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons (2009) PLoS One, 4 (8), p. 6591
Battaglia, G., Cannella, M., Riozzi, B., Orobello, S., Maat-Schieman, M.L., Aronica, E., Busceti, C.L., Squitieri, F., Early defect of transforming growth factor beta-1 formation in Huntington's disease (2010) J. Cell Mol. Med., 15, pp. 551-557
Battaglia, G., Riozzi, B., Molinaro, G., Bucci, D., Storto, M., Pallottino, M., Nicoletti, F., Bruno, V., Group-II mGluRs as drug targets in the treatment of amyotrophic lateral sclerosis (2011) Curr. Neuropharmacol., 9 (S1), p. 3
Berg, D., Godau, J., Trenkwalder, C., Eggert, K., Csoti, I., Storch, A., Huber, H., Gomez-Mancilla, B., AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials (2011) Mov. Disord., 26, pp. 1243-1250
Black, Y.D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A.L., Schwarzschild, M.A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165
Bond, A., O'Neill, M.J., Hicks, C.A., Monn, J.A., Lodge, D., Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia (1998) Neuroreport, 9, pp. 1191-1193
Bond, A., Ragumoorthy, N., Monn, J.A., Hicks, C.A., Ward, M.A., Lodge, D., O'Neill, M.J., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia (1999) Neurosci. Lett., 273, pp. 191-194
Bond, A., Jones, N.M., Hicks, C.A., Whiffin, G.M., Ward, M.A., O'Neill, M.F., Kingston, A.E., O'Neill, M.J., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo (2000) J. Pharmacol. Exp. Ther., 294, pp. 800-809
Brakeman, P.R., Lanahan, A.A., O'Brien, R., Roche, K., Barnes, C.A., Huganir, R.L., Worley, P.F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288
Brazil, D.P., Hemmings, B.A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664
Bruno, V., Copani, A., Battaglia, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death (1994) Eur. J. Pharmacol., 256, pp. 109-112
Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Activation of class II or class III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration (1995) Eur. J. Neurosci., 7, pp. 1906-1913
Bruno, V., Sureda, F.X., Storto, M., Casabona, G., Caruso, A., Knopfel, T., Kuhn, R., Nicoletti, F., The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling (1997) J. Neurosci., 17, pp. 1891-1897
Buisson, A., Choi, D.W., The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death (1995) Neuropharmacology, 34, pp. 1081-1087
Caraci, F., Molinaro, G., Battaglia, G., Giuffrida, M.L., Riozzi, B., Traficante, A., Bruno, V., Nicoletti, F., Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: Selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (2011) Mol. Pharmacol., 79, pp. 618-626
Caraci, F., Spampinato, S., Sortino, M.A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Copani, A., Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (2011) Cell Tissue Res., , 10.1007/s00441-011-1230-6
Caraci, F., Bosco, P., Signorelli, M., Spada R., .S., Cosentino F., .I., Toscano, G., Bonforte, C., Ferri, R., The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression (2011) Eur. Neuropsychopharmacol., , doi:10.1016/j.euroneuro.2011.08.006
Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., Caciagli, F., Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes (1999) Glia, 27, pp. 275-281
Cippitelli, A., Damadzic, R., Frankola, K., Goldstein, A., Thorsell, A., Singley, E., Eskay, R.L., Heilig, M., Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: Prevention by group II metabotropic glutamate receptor activation (2010) Biol. Psychiatry, 67, pp. 823-830
Conn, P.J., Battaglia, G., Marino, M.J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798
Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., Nicoletti, F., Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide (1995) Mol. Pharmacol., 47, pp. 890-897
Copani, A., Guccione, S., Giurato, L., Caraci, F., Calafiore, M., Sortino, M.A., Nicoletti, F., The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (2008) Curr. Med. Chem., 15, pp. 2420-2432
Corti, C., Battaglia, G., Molinaro, G., Riozzi, B., Pittaluga, A., Corsi, M., Mugnaini, M., Bruno, V., The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/ neuroprotection (2007) J. Neurosci., 27, pp. 8297-8308
Cozzi, A., Meli, E., Carlà, V., Pellicciari, R., Moroni, F., Pellegrini-Giampietro, D.E., Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity? (2002) Neuropharmacology, 43, pp. 119-130
D'Antoni, S., Berretta, A., Seminara, G., Longone, P., Giuffrida-Stella, A.M., Battaglia, G., Sortino, M.A., Catania, M.V., A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death (2011) Neurobiol. Dis., 42, pp. 252-264
De Vry, J., Horváth, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214
Di Liberto, V., Bonomo, A., Frinchi, M., Belluardo, N., Mudò, G., Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain (2010) Neuroscience, 165, pp. 863-873
Doherty, A.J., Palmer, M.J., Henley, J.M., Collingridge, G.L., Jane, D.E., (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267
D'Onofrio, M., Cuomo, L., Battaglia, G., Ngomba, R.T., Storto, M., Kingston, A.E., Orzi, F., Bruno, V., Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways (2001) J. Neurochem., 78, pp. 435-445
Duty, S., Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease (2010) Br. J. Pharmacol., 161, pp. 271-287
Emery, A.C., Pshenichkin, S., Takoudjou, G.R., Grajkowska, E., Wolfe, B.B., Wroblewski, J.T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, β-Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048
Emery A., .C., Hathaway, H., Pshenichkin, S., Takoudjou G., .R., Diraddo, J., Grajkowska, E., Yasuda R., .P., Wroblewski J., .T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18
Engers, D.W., Field, J.R., Le, U., Zhou, Y., Bolinger, J.D., Zamorano, R., Blobaum, A.L., Hopkins, C.R., Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110
Ferraguti, F., Shigemoto, R., Metabotropic glutamate receptors (2006) Cell Tissue Res., 326, pp. 483-504
Gasparini, F., Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Flor, P.J., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo (1999) J. Pharmacol. Exp. Ther., 289, pp. 1678-1687
Gill, S.S., Patel, N.K., Hotton, G.R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D.J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595
Hardingham, G.E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696
Henrich-Noack, P., Hatton, C.D., Reymann, K.G., The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils (1998) Neuroreport, 9, pp. 985-988
Herrero, I., Miras-Portugal, M.T., Sánchez-Prieto, J., Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors (1998) J. Biol. Chem., 273, pp. 1951-1958
Jantzie, L.L., Talos, D.M., Selip, D.B., An, L., Jackson, M.C., Folkerth, R.D., Deng, W., Jensen, F.E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12
Kinon, B.J., Zhang, L., Millen, B.A., Osuntokun, O.O., Williams, J.E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group
Kohara, A., Takahashi, M., Yatsugi, S., Tamura, S., Shitaka, Y., Hayashibe, S., Kawabata, S., Okada, M., Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models (2008) Brain Res., 1191, pp. 168-179
Koller, M., Urwyler, S., Novel N-methyl-d-aspartate receptor antagonists: A review of compounds patented since 2006 (2010) Exp. Opin. Ther. Pat., 20, pp. 1683-1702
Koo, S.J., Pfaff, S.L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826
Lam, A.G., Soriano, M.A., Monn, J.A., Schoepp, D.D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123
Landucci, E., Boscia, F., Gerace, E., Scartabelli, T., Cozzi, A., Moroni, F., Mannaioni, G., Pellegrini-Giampietro, D.E., Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia (2009) Int. Rev. Neurobiol., 85, pp. 337-350
Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., Pellegrini-Giampietro, D.E., CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices (2011) Neuropharmacology, 60, pp. 674-682
Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132
Lipton, P., Ischemic cell death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568
Lipton, S.A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170
Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J., Cotman, C.W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955
Maj, M., Bruno, V., Dragic, Z., Yamamoto, R., Battaglia, G., Inderbitzin, W., Stoehr, N., Flor, P.J., (-)-PHCCC, a positive allosteric modulator of mGluR4: Characterization, mechanism of action, and neuroprotection (2003) Neuropharmacology., 45, pp. 895-906
Makarewicz, D., Duszczyk, M., Gadamski, R., Danysz, W., Łazarewicz, J.W., Neuroprotective potential of group i metabotropic glutamate receptor antagonists in two ischemic models (2006) Neurochem. Int., 48, pp. 485-490
Mannaioni, G., Marino, M.J., Valenti, O., Traynelis, S.F., Conn, P.J., Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function (2001) J. Neurosci., 21, pp. 5925-5934
Marino, M.J., Williams, Jr.D.L., O'Brien, J.A., Valenti, O., McDonald, T.P., Clements, M.K., Wang, R., Conn, P.J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673
Masilamoni, G.J., Bogenpohl, J.W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J.R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073
Meldrum, B., Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission (1990) Cerebrovasc. Brain Metab. Rev., 2, pp. 27-57
Meli, E., Picca, R., Attucci, S., Cozzi, A., Peruginelli, F., Moroni, F., Pellegrini-Giampietro, D.E., Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo (2002) Pharmacol. Biochem. Behav., 73, pp. 439-446
Mermelstein, P.G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262
Micevych, P.E., Mermelstein, P.G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77
Miller, S., Sehati, N., Romano, C., Cotman, C.W., Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5 (1996) J. Neurochem., 67, pp. 1435-1447
Moroni, F., Attucci, S., Cozzi, A., Meli, E., Picca, R., Scheideler, M.A., Pellicciari, R., Pellegrini-Giampietro, D.E., The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death (2002) Neuropharmacology, 42, pp. 741-751
Moyanova, S.G., Mastroiacovo, F., Kortenska, L.V., Mitreva, R.G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R.T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118
Murotomi, K., Takagi, N., Takayanagi, G., Ono, M., Takeo, S., Tanonaka, K., MGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia (2008) J. Neurochem., 105, pp. 1625-1634
Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T., Pin, J.P., Metabotropic glutamate receptors: From the workbench to the bedside 2011 (2011) Neuropharmacology, 60, pp. 1017-1041
Niswender, C.M., Johnson, K.A., Weaver, C.D., Jones, C.K., Xiang, Z., Luo, Q., Rodriguez, A.L., Conn, P.J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358
Niswender, C.M., Conn, P.J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322
Olney, J.W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359
Olney, J.W., Wozniak, D.F., Farber, N.B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240
Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Schoepp, D.D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107
Pisani, A., Gubellini, P., Bonsi, P., Conquet, F., Picconi, B., Centonze, D., Bernardi, G., Calabresi, P., Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons (2001) Neuroscience, 106, pp. 579-587
Price, D.L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020
Pshenichkin, S., Dolińska, M., Klauzińska, M., Luchenko, V., Grajkowska, E., Wroblewski, J.T., Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - Possible role as a dependence receptor (2008) Neuropharmacology, 55, pp. 500-508
Pshenichkin, S., Emery A., .C., Takoudjou G., .R., Diraddo, J., Hathaway, H., Grajkowska, E., Wroblewski J., .T., Neuroprotective and neurotoxic signaling of mGlu1 receptors (2011) Current Neuropharmacology., 9 (S1), p. 54
Rong, R., Ahn, J.Y., Huang, H., Nagata, E., Kalman, D., Kapp, J.A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161
Rossi, D., Brambilla, L., Valori, C.F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D.E., Volterra, A., Focal degeneration of astrocytes in amyotrophic lateral sclerosis (2008) Cell Death Differ., 15, pp. 1691-1700
Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111
Rothstein, J.D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359
Schober, A., Peterziel, H., Von Bartheld, C.S., Simon, H., Krieglstein, K., Unsicker, K., GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action (2007) Neurobiol. Dis., 25, pp. 378-391
Schoepp, D.D., Jane, D.E., Monn, J.A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476
Siesjö, B.K., Katsura, K., Kristián, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52
Slevin, J.T., Gerhardt, G.A., Smith, C.D., Gash, D.M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222
Spampinato, S.F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M.A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta}-amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20
Taylor, D.L., Diemel, L.T., Pocock, J.M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160
Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Wyss-Coray, T., Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology (2006) J. Clin. Invest., 116, pp. 3060-3069
Thomas, A.G., Liu, W., Olkowski, J.L., Tang, Z., Lin, Q., Lu, X.C., Slusher, B.S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40
Thomsen, C., Bruno, V., Nicoletti, F., Marinozzi, M., Pellicciari, R., (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors (1996) Mol. Pharmacol., 50, pp. 6-9
Tu, J.C., Xiao, B., Yuan, J.P., Lanahan, A.A., Leoffert, K., Li, M., Linden, D.J., Worley, P.F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726
Valenti, O., Marino, M.J., Wittmann, M., Lis, E., Dilella, A.G., Kinney, G.G., Conn, P.J., Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse (2003) J. Neurosci., 23, pp. 7218-7226
Werner, C.G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D.E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604
Xu, W., Wong, T.P., Chery, N., Gaertner, T., Wang, Y.T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412
Yoshioka, H., Sugita, M., Kinouchi, H., Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia (2009) Neurosci. Lett., 461, pp. 266-270
Zhou, M., Xu, W., Liao, G., Bi, X., Baudry, M., Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation (2009) Exp. Neurol., 218, pp. 75-82
Zipfel, G.J., Lee, J.M., Choi, D.W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544
Albers, G. W., Goldberg, M. P., Choi, D. W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40
Armentero, M. T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9
Attucci, S., Carl, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806
Bal zs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C. W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163
Black, Y. D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A. L., Schwarzschild, M. A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165
Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., Worley, P. F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288
Brazil, D. P., Hemmings, B. A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664
Choi, D. W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
Conn, P. J., Battaglia, G., Marino, M. J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798
De Vry, J., Horv th, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu (1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214
Doherty, A. J., Palmer, M. J., Henley, J. M., Collingridge, G. L., Jane, D. E., (RS) -2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267
Emery, A. C., Pshenichkin, S., Takoudjou, G. R., Grajkowska, E., Wolfe, B. B., Wroblewski, J. T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, -Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048
Emery A., . C., Hathaway, H., Pshenichkin, S., Takoudjou G., . R., Diraddo, J., Grajkowska, E., Yasuda R., . P., Wroblewski J., . T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18
Engers, D. W., Field, J. R., Le, U., Zhou, Y., Bolinger, J. D., Zamorano, R., Blobaum, A. L., Hopkins, C. R., Discovery, synthesis, and structure-activity relationship development of a series of N- (4-acetamido) phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu (4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595
Hardingham, G. E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696
Jantzie, L. L., Talos, D. M., Selip, D. B., An, L., Jackson, M. C., Folkerth, R. D., Deng, W., Jensen, F. E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12
Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group
Koo, S. J., Pfaff, S. L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826
Lam, A. G., Soriano, M. A., Monn, J. A., Schoepp, D. D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123
Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132
Lipton, S. A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., Cotman, C. W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955
Marino, M. J., Williams, Jr. D. L., O'Brien, J. A., Valenti, O., McDonald, T. P., Clements, M. K., Wang, R., Conn, P. J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673
Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J. R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073
Mermelstein, P. G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262
Micevych, P. E., Mermelstein, P. G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77
Moyanova, S. G., Mastroiacovo, F., Kortenska, L. V., Mitreva, R. G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R. T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118
Niswender, C. M., Johnson, K. A., Weaver, C. D., Jones, C. K., Xiang, Z., Luo, Q., Rodriguez, A. L., Conn, P. J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358
Niswender, C. M., Conn, P. J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322
Olney, J. W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359
Olney, J. W., Wozniak, D. F., Farber, N. B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Schoepp, D. D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107
Price, D. L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020
Rong, R., Ahn, J. Y., Huang, H., Nagata, E., Kalman, D., Kapp, J. A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161
Rothman, S. M., Olney, J. W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111
Rothstein, J. D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359
Schoepp, D. D., Jane, D. E., Monn, J. A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476
Siesj, B. K., Katsura, K., Kristi n, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52
Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222
Spampinato, S. F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M. A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta} -amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20
Taylor, D. L., Diemel, L. T., Pocock, J. M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160
Thomas, A. G., Liu, W., Olkowski, J. L., Tang, Z., Lin, Q., Lu, X. C., Slusher, B. S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40
Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., Worley, P. F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726
Werner, C. G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D. E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604
Xu, W., Wong, T. P., Chery, N., Gaertner, T., Wang, Y. T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412
Zipfel, G. J., Lee, J. M., Choi, D. W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(349 views) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 ViewExport to BibTeXExport to EndNote